Nuclear receptors in head and neck cancer: current knowledge and perspectives
Open Access
- 8 December 2009
- journal article
- review article
- Published by Wiley in International Journal of Cancer
- Vol. 126 (4) , 801-809
Abstract
Disease management of head and neck cancer has improved significantly. However, a high rate of early recurrences and metastasis still counteract improvement of long‐term survival. Hence, the quest for molecular mechanisms and key regulatory factors exploitable by targeted therapies is still ongoing. Such potential candidates may include also nuclear receptors, belonging to a superfamily of transcription factors implicated in a broad spectrum of physiological and pathophysiological processes. As dysfunction of nuclear receptor signaling contributes to a variety of proliferative diseases, they are major targets for drug discovery and hold promising potential for the development of improved anticancer treatment strategies. Several nuclear receptors have also been associated with head and neck cancer, and strategies targeting these molecules are currently tested in clinical trials. However, reports and molecular knowledge on the pathobiological relevance of nuclear receptors for cancers of the head and neck is currently rather fragmented. Hence, this review provides a general overview of nuclear receptors' molecular functions and summarizes their potential prognostic and therapeutic relevance for this tumor entity.Keywords
This publication has 55 references indexed in Scilit:
- Therapeutic potential of nuclear receptorsExpert Opinion on Therapeutic Patents, 2008
- Head and Neck CancersJournal of the National Comprehensive Cancer Network, 2008
- Chemotherapy in the treatment of locally advanced head and neck cancerJournal of Surgical Oncology, 2008
- A multidisciplinary approach to squamous cell carcinomas of the head and neck: an updateCurrent Opinion in Oncology, 2008
- Treatment of Head and Neck CancerNew England Journal of Medicine, 2008
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI: Journal of the National Cancer Institute, 2008
- Dynamic survivin in head and neck cancer: Molecular mechanism and therapeutic potentialInternational Journal of Cancer, 2007
- Overview of Nomenclature of Nuclear ReceptorsPharmacological Reviews, 2006
- Head and Neck Cancer: Recent Advances and New Standards of CareJournal of Clinical Oncology, 2006
- Principles for modulation of the nuclear receptor superfamilyNature Reviews Drug Discovery, 2004